share_log

Delisting of Securities of China XD Plastics Company Limited and Advaxis, Inc. from The Nasdaq Stock Market

Delisting of Securities of China XD Plastics Company Limited and Advaxis, Inc. from The Nasdaq Stock Market

中國 XD 塑膠有限公司及 Advaxis 股份有限公司證券從納斯達克股票市場除牌
GlobeNewswire ·  2022/02/09 05:12

NEW YORK, Feb. 08, 2022 (GLOBE NEWSWIRE) --  The Nasdaq Stock Market announced today that it will delist the common stock of China XD Plastics Company Limited. China XD Plastics Company Limited's common stock was suspended on October 29, 2021 and has not traded on Nasdaq since that time.

紐約,2022 年 2 月 8 日(環球美通社)-納斯達克股票市場今天宣布將撤銷中國 XD 塑膠有限公司的普通股。中國 XD 塑膠有限公司的普通股於 2021 年 10 月 29 日停牌,自那時起一直沒有在納斯達克交易。

Nasdaq also announced today that it will delist the common stock of Advaxis, Inc. Advaxis, Inc.'s common stock was suspended on December 23, 2021 and has not traded on Nasdaq since that time.

納斯達克今天還宣布,它將取消 Advaxis 公司 Advaxis 股份有限公司的普通股。普通股於 2021 年 12 月 23 日暫停交易,自那時起一直沒有在納斯達克交易。

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.

納斯達克(Nasdaq)將向美國證券交易委員會提交 25 表格以完成交易。除牌日期在 25 表格提交後十天生效。有關公司的新聞和其他信息,包括除牌基礎以及該公司的證券是否在另一個地點買賣,請查看公司的公開文件或直接與該公司聯繫。

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series. 

有關納斯達克證券市場的更多信息,請訪問納斯達克網站納斯達克管理證券除牌規則的納斯達克網站,可以在納斯達克網站上找到納斯達克規則 5800 系列。https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series

NDAQO

恩达戈


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論